Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia.

Downes, Charlotte E J; McClure, Barbara J; Bruning, John B; Page, Elyse; Breen, James; Rehn, Jacqueline; Yeung, David T; White, Deborah L

Downes, Charlotte E J; McClure, Barbara J; Bruning, John B; Page, Elyse; Breen, James; Rehn, Jacqueline; Yeung, David T; White, Deborah L.

Afiliación

Downes CEJ; Cancer Program, Precision Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
McClure BJ; School of Biological Sciences, University of Adelaide, Adelaide, SA, Australia.
Bruning JB; Cancer Program, Precision Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Page E; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia.
Breen J; Institute of Photonics and Advanced Sensing, School of Biological Sciences, University of Adelaide, Adelaide, SA, Australia.
Rehn J; Cancer Program, Precision Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Yeung DT; School of Biological Sciences, University of Adelaide, Adelaide, SA, Australia.
White DL; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia.

NPJ Precis Oncol ; 5(1): 75, 2021 Aug 10.

Article en En | MEDLINE | ID: mdl-34376782

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Precis Oncol Año: 2021 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google